CoreCivic Inc
F:PSRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CoreCivic Inc
F:PSRA
|
US |
|
P
|
Pros Holdings Inc
F:PH2
|
US |
|
V
|
Vanda Pharmaceuticals Inc
XBER:VM4
|
US |
|
B
|
Becton Dickinson and Co
F:BOX
|
US |
|
A
|
Asia Pacific Securities JSC
VN:APS
|
VN |
|
B
|
Becton Dickinson and Co
DUS:BOX
|
US |
|
C
|
CenterPoint Energy Inc
XMUN:HOU
|
US |
|
L
|
Lincoln Electric Holdings Inc
F:LNE
|
US |
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
U
|
United Therapeutics Corp
XBER:UTH
|
US |
|
Fugro NV
F:F3DC
|
NL |
|
Vitura Health Ltd
ASX:VIT
|
AU |
Wall St Price Targets
PSRA Price Targets Summary
CoreCivic Inc
According to Wall Street analysts, the average 1-year price target for PSRA is 24.47 EUR with a low forecast of 23.08 EUR and a high forecast of 27.42 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PSRA's stock price target?
Price Target
24.47
EUR
According to Wall Street analysts, the average 1-year price target for PSRA is 24.47 EUR with a low forecast of 23.08 EUR and a high forecast of 27.42 EUR.
What is the Revenue forecast for CoreCivic Inc?
Projected CAGR
11%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 2 years is 11%.
What is the Operating Income forecast for CoreCivic Inc?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Operating Income has been -3%. The projected CAGR for the next 2 years is 21%.
What is the Net Income forecast for CoreCivic Inc?
Projected CAGR
29%
Over the last 14 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 2 years is 29%.
